CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Apr. 28, 2013	Apr. 29, 2012
Cash flows from operating activities:
Net income (loss)	$ (8,969)	$ 1,910
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	20,103	14,427
Share-based compensation expense	6,887	4,093
Loss on sale of property, plant and equipment	0	13
Provision for doubtful accounts	1,100	(692)
Provision (benefit) from deferred income taxes	(4,772)	1,147
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	19,812	12,561
Inventories	(19,764)	(18,373)
Income tax receivable	(381)	169
Prepaid expenses and other	286	(2,972)
Accounts payable	(15,425)	(2,899)
Accrued expenses	(2,389)	656
Other, net	(911)	(51)
Net cash (used in) provided by operating activities	(4,423)	9,989
Cash flows from investing activities:
Capital expenditures	(12,715)	(13,899)
Proceeds from sale of property, plant and equipment	0	37
Net cash used in investing activities	(12,715)	(13,862)
Cash flows from financing activities:
Proceeds from stock options exercised	674	0
Decrease in restricted cash	1,375	2,836
Payments on term loan	(10,375)	(2,200)
Payments on note payable	(593)	(403)
Payment of financing costs	(97)	(50)
Excess tax benefits from share-based compensation arrangements	948	1
Purchase of treasury stock	(2,369)	(1,510)
Net cash used in financing activities	(10,437)	(1,326)
Effect of exchange rate changes on cash and cash equivalents	(45)	73
Net decrease in cash and cash equivalents	(27,620)	(5,126)
Cash and cash equivalents at beginning of period	55,158	78,982
Cash and cash equivalents at end of period	$ 27,538	$ 73,856